Medicina, Volume 60, Issue 12
2024 December - 205 articles
Cover Story: Chronic respiratory disorders are the leading cause of mortality worldwide, necessitating the continuous search for novel therapeutic interventions. GLP-1 and GIP/GLP-1 receptor agonists, in addition to their role in the regulation of glycemia and weight, have potential in the treatment of respiratory disorders due to their diverse biological effects. This article scrutinizes the evidence relating to their direct and indirect effects on pulmonary tissues and evaluates their efficacy in the context of conditions such as COPD, asthma, pneumonia, sleep apnea, pulmonary hypertension, lung cancer, and lung transplantation. Additionally, it delineates avenues for future research within this domain. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.